New Jersey Hematology Oncology Associates — Brick, New Jersey

New Jersey Hematology Oncology Associates is a clinical research site located in Brick, New Jersey, United States 08724-3009.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

New Jersey Hematology Oncology Associates has participated in 18 clinical trials with 1 currently active.

Therapeutic areas: Myelofibrosis, Polycythemia Vera, Thrombocythemia.

Sponsors: Incyte Corporation, Takeda, KangLaiTe USA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Brick

Browse all research sites in New Jersey · View every site in Brick

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Hematology Oncology Associates?

New Jersey Hematology Oncology Associates has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Hematology Oncology Associates conducted?

New Jersey Hematology Oncology Associates has 18 clinical trials on record, with 1 currently active. Their work covers Myelofibrosis, Polycythemia Vera, Thrombocythemia.

Is New Jersey Hematology Oncology Associates accredited by Crixeo Clinical Trials?

New Jersey Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey Hematology Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.